Sign Up to like & get
recommendations!
1
Published in 2018 at "Pulmonology"
DOI: 10.1016/j.pulmoe.2018.10.002
Abstract: The publisher informs that the authorship of the article ‘‘Tuberculosis and gender -Factors influencing the risk of tuberculosis among men and women by age group’’, published in Pulmonology 2018;24(3):199--202 is not complete. The full authorship…
read more here.
Keywords:
tuberculosis gender;
gender factors;
risk tuberculosis;
tuberculosis ... See more keywords
Sign Up to like & get
recommendations!
0
Published in 2022 at "Transplant Infectious Disease"
DOI: 10.1111/tid.13963
Abstract: Rituximab is an anti‐CD 20 agent used widely in renal transplant recipients. Its use is associated with various infections; however, its association with tuberculosis (TB) is not well established and has not been studied in…
read more here.
Keywords:
rituximab;
risk tuberculosis;
renal transplant;
transplant recipients ... See more keywords
Sign Up to like & get
recommendations!
1
Published in 2022 at "Journal of Personalized Medicine"
DOI: 10.3390/jpm12071189
Abstract: Background: In chronic obstructive pulmonary disease (COPD), inhaled corticosteroids (ICSs) are recommended for use by patients with frequent exacerbations and blood eosinophilia. However, ICSs are often inappropriately prescribed and overused. COPD studies have reported an…
read more here.
Keywords:
tuberculosis;
chronic obstructive;
fluticasone propionate;
risk tuberculosis ... See more keywords
Sign Up to like & get
recommendations!
2
Published in 2022 at "Life"
DOI: 10.3390/life12111881
Abstract: We investigated the role of vitamin D in the risk of tuberculosis (TB) among patients with end-stage kidney disease (ESKD). The retrospective cohort was conducted with data of 20,985 patients with kidney disease and 20,985…
read more here.
Keywords:
disease;
risk tuberculosis;
kidney disease;
Sign Up to like & get
recommendations!
1
Published in 2017 at "Clinical and Experimental Dermatology"
DOI: 10.5578/ced.201719
Abstract: The clinical use of TNF-alpha inhibitors have been increasing in the treatment of autoimmune disorders. The most common anti-TNF-alpha agents on clinical use are ethanercept, infliximab and adalimumab. TNFalpha is an important mediator in the…
read more here.
Keywords:
risk tuberculosis;
alpha inhibitors;
alpha;
tnf alpha ... See more keywords
Sign Up to like & get
recommendations!
0
Published in 2019 at "Clinical Medicine"
DOI: 10.7861/clinmedicine.19-2-s117
Abstract: Tumour necrosis factor-alpha inhibitors (TNFi) increase the risk of reactivation of latent tuberculosis (TB). The objective of this review was to assess the risk of tuberculosis in patients receiving TNFi therapy and to compare the…
read more here.
Keywords:
necrosis factor;
risk;
risk tuberculosis;
tuberculosis ... See more keywords